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Kayla N. Stilger 
PROSTAGLANDIN E2 PROMOTES RECOVERY OF HEMATOPOIETIC STEM AND 
PROGENITOR CELLS AFTER RADIATION EXPOSURE 
 
The hematopoietic system is highly proliferative, making hematopoietic stem 
and progenitor cells (HSPC) sensitive to radiation damage. Total body irradiation and 
chemotherapy, as well as the risk of radiation accident, create a need for 
countermeasures that promote recovery of hematopoiesis. Substantive damage to the 
bone marrow from radiation exposure results in the hematopoietic syndrome of the 
acute radiation syndrome (HS-ARS), which includes life-threatening neutropenia, 
lymphocytopenia, thrombocytopenia, and possible death due to infection and/or 
hemorrhage. Given adequate time to recover, expand, and appropriately differentiate, 
bone marrow HSPC may overcome HS-ARS and restore homeostasis of the 
hematopoietic system. Prostaglandin E2 (PGE2) is known to have pleiotropic effects on 
hematopoiesis, inhibiting apoptosis and promoting self-renewal of hematopoietic stem 
cells (HSC), while inhibiting hematopoietic progenitor cell (HPC) proliferation. We 
assessed the radiomitigation potential of modulating PGE2 signaling in a mouse model of 
HS-ARS. Treatment with the PGE2 analog 16,16 dimethyl PGE2 (dmPGE2) at 24 hours 
post-irradiation resulted in increased survival of irradiated mice compared to vehicle 
control, with greater recovery in HPC number and colony-forming potential measured at 
30 days post-irradiation. In a sublethal mouse model of irradiation, dmPGE2-treatment 
at 24 hours post-irradiation is associated with enhanced recovery of HSPC populations 
v 
 
compared to vehicle-treated mice. Furthermore, dmPGE2-treatment may also act to 
promote recovery of the HSC niche through enhancement of osteoblast-supporting 
megakaryocyte (MK) migration to the endosteal surface of bone. A 2-fold increase in 
MKs within 40 um of the endosteum of cortical bone was seen at 48 hours post-
irradiation in mice treated with dmPGE2 compared to mice treated with vehicle control. 
Treatment with the non-steroidal anti-inflammatory drug (NSAID) meloxicam abrogated 
this effect, suggesting an important role for PGE2 signaling in MK migration. In vitro 
assays support this data, showing that treatment with dmPGE2 increases MK expression 
of the chemokine receptor CXCR4 and enhances migration to its ligand SDF-1, which is 
produced by osteoblasts. Our results demonstrate the ability of dmPGE2 to act as an 
effective radiomitigative agent, promoting recovery of HSPC number and enhancing 
migration of MKs to the endosteum where they play a valuable role in niche restoration. 
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